Regencell Bioscience Holdings Limited
NASDAQ:RGC
15.29 (USD) • At close July 16, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Operating Activities: | ||||||
| Net Income
| -4.363 | -6.062 | -7.595 | -1.347 | -0.812 | -0.391 |
| Depreciation & Amortization
| 0.746 | 0.77 | 0.604 | 0.026 | 0.01 | 0 |
| Deferred Income Tax
| 0 | 0.001 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.449 | 0.923 | 2.758 | 0 | 0 | 0 |
| Change In Working Capital
| -0.585 | -0.509 | -1.024 | 0.553 | 0.076 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -0.585 | -0.509 | -1.024 | 0.553 | 0.076 | 0 |
| Other Non Cash Items
| -0.248 | -0.085 | -0.011 | 0.053 | 0.019 | 0 |
| Operating Cash Flow
| -4.002 | -4.963 | -5.267 | -0.767 | -0.727 | -0.391 |
| Investing Activities: | ||||||
| Investments In Property Plant And Equipment
| -0.005 | -0.027 | -0.781 | 0 | -0.118 | 0 |
| Acquisitions Net
| 0 | 0.001 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -5 | -10 | -10 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 10.248 | 10.085 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -0.01 | 0 | 0 | 0 |
| Investing Cash Flow
| 5.243 | 0.059 | -10.781 | 0 | -0.118 | 0 |
| Financing Activities: | ||||||
| Debt Repayment
| 0 | 0 | 0 | 0.612 | 0.988 | 0.481 |
| Common Stock Issued
| 0 | 0 | 22.673 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.102 | 0.135 | -0.268 | -0.172 | 0 | 0 |
| Financing Cash Flow
| 0.102 | 0.135 | 22.406 | 0.44 | 0.988 | 0.481 |
| Other Information: | ||||||
| Effect Of Forex Changes On Cash
| 0.053 | -0.083 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 1.396 | -4.852 | 6.358 | -0.328 | 0.144 | 0.09 |
| Cash At End Of Period
| 2.961 | 1.565 | 6.417 | 0.059 | 0.387 | 0.243 |